Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple ...

Despite high specificity, the tests show low sensitivity for early-stage cancers, necessitating further validation through ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

Camizestrant plus CDK4/6 inhibition improved progression-free survival when given to patients with ESR1-mutant ER+/HER2– ...